Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Selective

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,005Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Palatin Presents Data On Selective Melanocortin 4 Receptor Agonists
    Palatin Presents Data On Selective Melanocortin 4 Receptor Agonists

    23 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/palatin-presents-foundational-data-on-novel-and-highly-selective-melanocortin-4-receptor-agonists-at-the-19th-annual-peptide-therapeutics-symposium-302284068.html

    PR NEWSWIRE
    23 Oct 2024
    Share Share
    BerGenBio Selects 2nd Dose For Phase 2a STK11m NSCLC Trial
    BerGenBio Selects 2nd Dose For Phase 2a STK11m NSCLC Trial

    29 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bergenbio-announces-selection-of-2nd-dose-in-phase-2a-first-line-stk11m-non-small-lung-cancer-trial-302208346.html

    PR NEWSWIRE
    29 Jul 2024
    Share Share
    Artelo's ART26.12 IND Application Cleared By FDA
    Artelo's ART26.12 IND Application Cleared By FDA

    15 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/15/2913045/0/en/Artelo-Biosciences-Receives-FDA-Clearance-of-its-IND-Application-for-ART26-12-a-Selective-Fatty-Acid-Binding-Protein-5-Inhibitor.html

    GLOBENEWSWIRE
    15 Jul 2024
    Share Share
    Aprea Therapeutics Hosts Virtual KOL Event on APR-1051 on June 24
    Aprea Therapeutics Hosts Virtual KOL Event on APR-1051 on June 24

    21 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/21/2902256/0/en/Aprea-Therapeutics-to-Host-Virtual-KOL-Event-on-APR-1051-a-Highly-Selective-and-Potentially-Best-in-Class-Oral-WEE1-Inhibitor-on-Monday-June-24-2024.html

    GLOBENEWSWIRE
    21 Jun 2024
    Share Share
    SeaStar Medical’s Cytopheretic Device Featured in Two PPT at the 42nd Vicenza
    SeaStar Medical’s Cytopheretic Device Featured in Two PPT at the 42nd Vicenza

    11 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/11/2896787/0/en/SeaStar-Medical-s-Selective-Cytopheretic-Device-Featured-in-Two-Presentations-at-the-42nd-Vicenza-Course-AKI-CRT-ECOS-and-Critical-Care-Nephrology.html

    GLOBENEWSWIRE
    11 Jun 2024
    Share Share
    Nature Paper Details SeaStar's Inflammation Control Mechanism
    Nature Paper Details SeaStar's Inflammation Control Mechanism

    07 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/07/2895362/0/en/Article-in-Nature-Scientific-Reports-Describes-Mechanism-of-Action-of-SeaStar-Medical-s-Selective-Cytopheretic-Device-in-the-Immunomodulation-of-Excessive-Inflammation.html

    GLOBENEWSWIRE
    07 Jun 2024
    Share Share